China Digest: Zonsen Biotech bags $34m; 6cloud raises $23m
Photo: Bloomberg
April 30, 2021
Zonsen Peplib Biotech has secured 220 million yuan ($34 million) in a Series A+ round of financing, while 6cloud Tech has raised 150 million yuan ($23 million) in a Series C round of financing from Ying Capital, and others.
Zonsen Biotech bags $34m in Series A+ round
Drug discovery platform Zonsen Peplib Biotech Co. Ltd (Zonsen Biotech) has raked in 220 million yuan ($34 million) in a Series A+ round of financing led by CDH Wealth Management an alternative asset management platform of CDH Investments with over $1.6 billion in assets under management.
Legend Star, along with a slew of investors, including ASB Ventures, healthcare-focused Highlight Capital, Shenzhen-based Cowin Capital, and Fortune Capital have collectively participated in the current round, according to a company statement on April 29.